Endeavour

Biotechnology and Pharmaceuticals

Health

Sutro Biopharma, Inc.

Sutro Biopharma, Inc. is a public biotechnology company headquartered in South San Francisco, California focused on clinical stage drug discovery, development and manufacturing company. Using its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics for cancer and autoimmune disorders. It focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidates include STRO-001 and STRO-002. STRO-001 is an ADC directed against the cancer target CD74, for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002 is an ADC directed against folate receptor-alpha (FolRa), for patients with ovarian and endometrial cancers. STRO-001 and STRO-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its XpressCF platform.

youtube

twitter

linkedin

facebook

Sutro Biopharma, Inc. With a focus on clinical stage drug discovery, development, and manufacturing, Sutro Biopharma utilizes its innovative integrated cell-free protein synthesis platform, XpressCF, to create a range of protein therapeutics for cancer and autoimmune disorders. The company is dedicated to designing potent therapeutics using various modalities, including cytokine-based immune-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs), and bispecific antibodies that target clinically validated targets. Sutro's product candidates, STRO-001 and STRO-002, are antibody-drug conjugates directed against cancer targets CD74 and folate receptor-alpha (FolRa) respectively. These candidates have been optimized for therapeutic index using the XpressCF platform. Sutro Biopharma is committed to providing innovative and effective therapies to cancer patients, advancing the field of oncology, and improving patients' lives.